34.37

2.55% -0.90

Tectonic Therapeutic Inc (TECX)

Overview News Price History Discussions Forecast

Tectonic Therapeutic Inc stock is traded at $34.37, with a volume of 100.57K. It is down -2.55% in the last 24 hours and up +22.53% over the past month. Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Previous Close:

$35.27

Open:

$35.58

24h Volume:

100.57K

Relative Volume:

0.49

Market Cap:

$648.53M

Revenue:

Net Income/Loss:

$-83.49M

P/E Ratio:

-7.7115

EPS:

-4.457

Net Cash Flow:

$-60.29M

1W Performance:

-9.39%

1M Performance:

+22.53%

6M Performance:

+67.17%

1Y Performance:

+58.24%

1-Day Range:

$33.86

$35.58

1-Week Range:

$33.86

$39.53

52-Week Range:

$14.38

$39.53

Tectonic Therapeutic Inc Stock (TECX) Company Profile

Name

Tectonic Therapeutic Inc

Sector

Healthcare (1096)

Industry

Biotechnology (616)

Phone

(339) 666-3320

Address

490 ARSENAL WAY, WATERTOWN

Employee

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

TECX's Discussions on Twitter

Compare TECX vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TECX Tectonic Therapeutic Inc	34.37	648.53M	0	-83.49M	-60.29M	-4.457
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-14-26	Initiated	Stifel	Buy
Oct-20-25	Initiated	Wells Fargo	Overweight
Sep-03-25	Initiated	Oppenheimer	Outperform
Jul-21-25	Initiated	Truist	Buy
Jun-11-25	Resumed	Raymond James	Outperform
Apr-21-25	Initiated	Mizuho	Outperform
Nov-20-24	Initiated	Raymond James	Outperform
Aug-22-24	Initiated	Wells Fargo	Overweight
Jun-26-24	Initiated	Piper Sandler	Overweight
Jun-24-24	Initiated	TD Cowen	Buy
Dec-18-23	Downgrade	Mizuho	Buy → Neutral
Jan-05-22	Downgrade	BTIG Research	Buy → Neutral
Nov-19-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-15-21	Initiated	BTIG Research	Buy
May-27-21	Initiated	Needham	Buy
Mar-09-21	Initiated	Barclays	Overweight
Mar-02-21	Initiated	Stifel	Hold
Nov-11-20	Initiated	Berenberg	Buy
Mar-31-20	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-27-19	Initiated	Mizuho	Buy
Apr-05-19	Initiated	Janney	Buy
Oct-10-18	Initiated	Guggenheim	Buy
Oct-02-18	Reiterated	H.C. Wainwright	Buy
Sep-17-18	Initiated	H.C. Wainwright	Buy
Jul-16-18	Initiated	Wedbush	Outperform
Jul-16-18	Initiated	Wells Fargo	Outperform

View All

Tectonic Therapeutic Inc Stock (TECX) Latest News

Jul 09, 2026

Here's Why We're Not Too Worried About Tectonic Therapeutic's (NASDAQ:TECX) Cash Burn Situation - Moomoo

Jul 09, 2026

We're Hopeful That Tectonic Therapeutic (NASDAQ:TECX) Will Use Its Cash Wisely - Sahm

Jul 09, 2026

Jul 05, 2026

MSN Money - MSN

Jul 05, 2026

Jul 03, 2026

achievement unlocked! - Moomoo

Jul 03, 2026

Jul 01, 2026

Tectonic Therapeutic (TECX) CSO exercises options and sells 172 shares under 10b5-1 plan - Stock Titan

Jul 01, 2026

Jun 30, 2026

Form 144 TECTONIC THERAPEUTIC For: 30 June By Investing.com - Investing.com Nigeria

Jun 30, 2026

[144] Tectonic Therapeutic, Inc. SEC Filing - Stock Titan

Jun 30, 2026

Jun 27, 2026

Tectonic Therapeutic (TECX) Stages a 3% Rally: Key Levels to Watch for Continued MomentumEnding Diagonal - dars.gov.et

Jun 27, 2026

Jun 25, 2026

Tectonic Therapeutic Inc Actuals & Estimates (NASDAQ:TECX) - TradingView

Jun 25, 2026

TECX Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 23, 2026

Form 4 Tectonic Therapeutic Inc For: 23 June By Investing.com - Investing.com South Africa

Jun 23, 2026

Tectonic Therapeutic (TECX) CEO logs routine tax withholding on vested RSUs - Stock Titan

Jun 23, 2026

Jun 21, 2026

TECXTectonic Therapeutic Inc Short Interest - Finviz

Jun 21, 2026

Jun 19, 2026